Quotidiano Nazionale logo
quotidiano nazionale
6 dic 2021
6 dic 2021

Covid, Ema autorizza il tocilizumab per cura pazienti gravi: "Riduce il rischio di morte"

Via libera dell'agenzia europea al farmaco RoActemra già utilizzato per le artriti, ma solo nei malati che necessitano di ossigeno o ventilazione meccanica e già sottoposti a terapia sistemica con corticosteroidi

6 dic 2021
epa05266880 (FILE) A file photo dated 12 August 2005 showing the logo of Swiss drugmaker Roche in Basel, Switzerland. Roche released their 1st quarter 2016 results 19 April 2016, saying the group sales in the 1st quarter of 2016 rose 4 per cent to 12.4 billion Swiss Francs. Sales in the Pharmaceuticals Division were up 4 per cent to 9.8 billion Swiss Francs with Europe growing 5 per cent, driven by Perjeta, MabThera and RoActemra. Pharmaceuticals sales in USA increased 3 per cent, led by Esbriet, Xolair and HER2-positive breast cancer medicines.  EPA/STEFFEN SCHMIDT
L'azienda Roche produce il Roactemra (Ansa)
epa05266880 (FILE) A file photo dated 12 August 2005 showing the logo of Swiss drugmaker Roche in Basel, Switzerland. Roche released their 1st quarter 2016 results 19 April 2016, saying the group sales in the 1st quarter of 2016 rose 4 per cent to 12.4 billion Swiss Francs. Sales in the Pharmaceuticals Division were up 4 per cent to 9.8 billion Swiss Francs with Europe growing 5 per cent, driven by Perjeta, MabThera and RoActemra. Pharmaceuticals sales in USA increased 3 per cent, led by Esbriet, Xolair and HER2-positive breast cancer medicines.  EPA/STEFFEN SCHMIDT
L'azienda Roche produce il Roactemra (Ansa)

© Riproduzione riservata

Iscriviti alla newsletter.

Il modo più facile per rimanere sempre aggiornati

Hai già un account?